AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
4.610
0.00 (0.00%)
Jul 24, 2026, 4:00 PM EDT - Market closed
AVITA Medical Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 72.35 | 71.61 | 64.25 | 50.14 | 34.42 | 29.23 |
Revenue Growth | 0.96% | 11.45% | 28.14% | 45.68% | 17.75% | 104.95% |
Gross Profit Gross Profit Growth | 58.86 | 58.82 | 55.16 | 42.36 | 28.38 | 23.28 |
Operating Income Operating Income Growth | -39.51 | -42.53 | -56.59 | -42.66 | -27.51 | -26.54 |
Net Income Net Income Growth | -10.61 | -48.59 | -61.85 | -35.38 | -26.67 | -26.58 |
Earnings Per Share EPS Growth | -31.40 | -34.80 | -47.80 | -28.00 | -21.40 | -23.40 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 69.6 | 68.79 | 62.16 | 46.36 | 33.26 | 32.73 |
Japan Japan Growth | 1.89 | 2.09 | 1.43 | 3.37 | 0.73 | - |
European Union European Union Growth | - | 0.05 | 0.16 | 0.05 | - | - |
Australia Australia Growth | 0.2 | 0.2 | 0.31 | 0.22 | 0.28 | 0.21 |
United Kingdom United Kingdom Growth | 0.65 | 0.49 | 0.2 | 0.14 | 0.16 | 0.09 |
Total Total Growth | 72.35 | 71.61 | 64.25 | 50.14 | 34.42 | 33.03 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 14.26 | 18.19 | 35.89 | 89.06 | 79.34 | 110.75 |
Total Debt Total Debt Growth | 48.12 | 42.98 | 42.25 | 39.81 | 0 | 0 |
Net Cash (Debt) Net Cash Growth | -33.86 | -24.8 | -6.36 | 49.25 | 79.34 | 110.75 |
Net Cash Growth | - | - | - | -37.93% | -28.36% | 50.39% |
Net Cash Per Share Net Cash Per Share Growth | -23.41 | -17.80 | -4.91 | 38.88 | 63.47 | 97.68 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -45.02 | -48.59 | -61.85 | -35.38 | -26.67 | -26.58 |
Free Cash Flow Free Cash Flow Growth | -45.02 | -48.59 | -61.85 | -35.38 | -26.67 | -26.58 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 81.36% | 82.13% | 85.85% | 84.48% | 82.45% | 79.65% |
Operating Margin | -54.62% | -59.40% | -88.08% | -85.07% | -79.91% | -90.79% |
Pretax Margin | -62.68% | -67.83% | -96.17% | -70.43% | -77.36% | -90.81% |
Profit Margin | -62.68% | -67.85% | -96.26% | -70.56% | -77.47% | -90.94% |
FCF Margin | -62.23% | -67.85% | -96.26% | -70.56% | -77.47% | -90.94% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 1.96 | 0.07 | 0.26 | 0.35 | 0.24 | - |